3D Cell Culture Global Market – Forecast To 2028

Cell culture is an indispensable in-vitro tool used to understand the cell biology, the tissue morphology, mechanisms of diseases and drug action. The 3D cell culture technologies are emerging as an important tool over the conventional 2D cell culture system which can facilitate research in the biomedical field with more realistic results. 3D cell culture models such as Organoids, spheroids are showing great potential in many applications including basic research, cancer research, stem cell research, drug discovery & toxicity screening and regenerative medicine to better understand complex biology in a physiologically relevant context where 2D models have not proven as successful. Further development of advanced 3D cell culture products or technologies and emerging high potential bioprinting technologies will further expands the 3D cell culture applications areas and increase their adoption.

The 3D Cell culture global market is expected to grow at a mid teen CAGR from 2021 to 2028 to reach $2,867.1 million by 2028. The factors such as increasing funding towards the cell based research, increasing focus towards the application 3D cell culture models in in-vitro testing in drug discovery, toxicity testing due to advantages over 2D cell culture system are driving the 3D cell culture market. Whereas, growing focus towards application of 3D cell culture in the personalized and regenerative medicine and advancement is 3D cell culture technologies will provide immense growth opportunities for the 3D cell culture market. However, lack of skilled personnel, lack of standardization and high cost associated with 3D cell culture, ethical issues associated with 3D cell culture and stringent process control for handling 3D cell culture expected to hamper the market growth.

The market for 3D cell culture is segmented based on technology, products, end-user and geography. Based on the technology, the market is segmented into scaffold based platforms, scaffold free platforms and bioprinting. Among technologies, Scaffold based platforms is accounted for the highest revenue in 2021 and is expected to grow at a low teen CAGR from 2021 to 2028. Scaffold free platforms are expected to grow at a mid teen CAGR from 2021 to 2028. The scaffold based platforms is further segmented into solid scaffolds, hydrogels and others. Among these, Solid Scaffolds segment is accounted for the highest revenue in 2021 and is expected to grow at a low teen CAGR from 2021 to 2028. Hydrogels is expected to grow at a mid teen CAGR from 2021 to 2028. The scaffold free platforms is further sub-segmented into hanging drop method, agitation based method, forced floating and microfluidics. Among these, Forced floating segment is accounted for the highest revenue in 2021 and is expected to grow at a mid teen CAGR from 2021 to 2028. Microfluidics is expected to grow at a high teen CAGR from 2021 to 2028.

Based on the products, the 3D cell culture market is classified into Cells & tissues, Media, Sera and Reagents, Microplates & Others, assay kits, scaffolds and Instruments. Among the products, media, sera and reagents accounted for the highest revenue in 2021 and are expected to grow at a mid teen CAGR from 2021 to 2028. Scaffolds segment is expected to grow at a mid teen CAGR from 2021 to 2028.

Based on applications the 3D cell culture market is divided into basic research, toxicity and drug safety screening, tissue engineering, stem cell research, drug discovery, cancer research, and others. Among the applications, cancer research accounted for the highest revenue in 2021 and is expected to grow at a mid teen CAGR from 2021 to 2028. Stem cell research is expected to grow at a mid teen CAGR from 2021 to 2028.

Based on end users, 3D cell culture market is segmented into academic and research institutes, biotechnology and pharmaceutical industry, and others. Among these Biotechnology & Pharmaceutical segment is accounted for the highest revenue in 2021 and is expected to grow at a mid teen CAGR from 2021 to 2028. Other end-user such as CRO’s is expected to grow at a mid teen CAGR from 2021 to 2028 due to increasing focus towards the adoption of 3D cell culture model in drug discovery by the CRO’s.

By geography, the 3D cell culture global market is segmented into North America, Europe, Asia-Pacific and the Rest of the world. North America accounted for the largest revenue of in 2021 and is expected to grow at a low teen CAGR from 2021 to 2028. Europe is expected to grow at a mid teen CAGR from 2021 to 2028.

In spite of negative supply chain impact, the market witnessed positive demand in case of COVID-19 research, as 3D cell culture models were effectively employed to study host–virus interactions, and the disease course of COVID-19.

The 3D cell culture market is consolidated; the top 6 player’s occupied XX% of the market share and the remaining XX% of the market is occupied by other players. Companies are adopting various organic and inorganic strategies to expand their market in a competitive market. To gain market share, companies are constantly focusing on developing innovative technologies and differentiated products.

The key players in the 3D cell culture global market include Thermo Fisher Scientific (U.S.), Corning (U.S.), Lonza (Switzerland), Merck KGaA (Germany), Insphero (Switzerland), Reprocell (Japan), Greiner-Bio (Austria), Mimetas (Netherlands), Aspect Biosystem (Canada), BICO (Sweden) and 3D systems (U.S.).          

Contact:
Yashavanth BT
Business development executive
Phone : 0229-+918147030229
Email : yashavanth.b@iq4i.com